Johnson & Johnson reportedly will put up for review its $2.5 billion to $3 billion global media account, once it wraps a deal to acquire Pfizer's over-the-counter drug and personal-care business. Incumbents for J&J include Omnicom Group's OMD Worldwide and Interpublic Group's Universal McCann, while Aegis Group's Carat is the incumbent on the Pfizer brands slated for acquisition.

Related Summaries